FERNANDO ANTONIO
RODRÍGUEZ DE FONSECA
Catedrático de universidad
Publicaciones en las que colabora con FERNANDO ANTONIO RODRÍGUEZ DE FONSECA (82)
2023
-
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
International journal of molecular sciences, Vol. 24, Núm. 11
-
Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
Drug and Alcohol Dependence, Vol. 245
-
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 21
-
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"
Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461
-
Gut microbiota and voluntary alcohol consumption
Translational Psychiatry, Vol. 12, Núm. 1
-
Niveles plasmáticos de midkina en pacientes con trastorno por uso de cocaína en abstinencia
Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 273-277
-
Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission
IJID Regions, Vol. 4, pp. 10-16
-
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Biomedicines, Vol. 10, Núm. 5
2021
-
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking
Addiction Biology, Vol. 26, Núm. 3
-
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
Scientific Reports, Vol. 11, Núm. 1
-
Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain
Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264
-
The immune system through the lens of alcohol intake and gut microbiota
International Journal of Molecular Sciences, Vol. 22, Núm. 14
-
Trastorno por uso de cocaína y depresión: Cuando el diagnóstico clínico no es suficiente
Adicciones: Revista de socidrogalcohol, Vol. 33, Núm. 3, pp. 193-200
2020
-
Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala
Addiction Biology, Vol. 25, Núm. 5
-
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β
Neuropharmacology, Vol. 162
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1